Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2012 2
2013 1
2015 2
2016 7
2017 7
2018 8
2019 11
2020 15
2021 14
2022 10
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean evangelos eleutherakispapaiakovou (1 results)?
Antiresorptive treatment-associated ONJ.
Eleutherakis-Papaiakovou E, Bamias A. Eleutherakis-Papaiakovou E, et al. Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12787. Epub 2017 Oct 24. Eur J Cancer Care (Engl). 2017. PMID: 29063702 Review.
Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More.
Kostopoulos IV, Ntanasis-Stathopoulos I, Rousakis P, Eleutherakis-Papaiakovou E, Panteli C, Malandrakis P, Angelis N, Kanellias N, Orologas-Stavrou N, Papanota A, Fotiou D, Migkou M, Gavriatopoulou M, Kastritis E, Tsitsilonis O, Terpos E, Dimopoulos MA. Kostopoulos IV, et al. Among authors: eleutherakis papaiakovou e. J Clin Oncol. 2023 Jan 20;41(3):708-710. doi: 10.1200/JCO.22.01606. Epub 2022 Sep 30. J Clin Oncol. 2023. PMID: 36179274 No abstract available.
Efficacy of Panobinostat for the Treatment of Multiple Myeloma.
Eleutherakis-Papaiakovou E, Kanellias N, Kastritis E, Gavriatopoulou M, Terpos E, Dimopoulos MA. Eleutherakis-Papaiakovou E, et al. J Oncol. 2020 Jan 13;2020:7131802. doi: 10.1155/2020/7131802. eCollection 2020. J Oncol. 2020. PMID: 32411240 Free PMC article. Review.
Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab-based therapy.
Theodorakakou F, Fotiou D, Spiliopoulou V, Roussou M, Malandrakis P, Ntanasis-Stathopoulos I, Migkou M, Eleutherakis-Papaiakovou E, Kanellias N, Papanikolaou A, Gavriatopoulou M, Terpos E, Dimopoulos MA, Kastritis E. Theodorakakou F, et al. Among authors: eleutherakis papaiakovou e. Br J Haematol. 2023 Nov;203(3):411-415. doi: 10.1111/bjh.19042. Epub 2023 Aug 14. Br J Haematol. 2023. PMID: 37580907
Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation.
Eleutherakis Papaiakovou E, Terpos E, Kanellias N, Migkou M, Gavriatopoulou M, Ntanasis-Stathopoulos I, Fotiou D, Malandrakis P, Theodorakakou F, Spiliopoulou V, Kostopoulos IV, Tsitsiloni O, Tsirigotis P, Dimopoulos MA, Kastritis E. Eleutherakis Papaiakovou E, et al. Leuk Lymphoma. 2023 Dec;64(13):2140-2147. doi: 10.1080/10428194.2023.2253479. Epub 2023 Sep 1. Leuk Lymphoma. 2023. PMID: 37655597
Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies.
Fotiou D, Theodorakakou F, Gavriatopoulou M, Migkou M, Malandrakis P, Ntanasis-Stathopoulos I, Kanellias N, Eleutherakis Papaiakovou E, Terpos E, Papanikolaou A, Gakiopoulou C, Dimopoulos MA, Kastritis E. Fotiou D, et al. Among authors: eleutherakis papaiakovou e. Eur J Haematol. 2023 Aug;111(2):271-278. doi: 10.1111/ejh.13993. Epub 2023 May 23. Eur J Haematol. 2023. PMID: 37218632
Prevalence of MGCS Among Patients With Monoclonal Gammopathies.
Theodorakakou F, Fotiou D, Gavriatopoulou M, Ntanasis-Stathopoulos I, Spiliopoulou V, Malandrakis P, Migkou M, Eleutherakis-Papaiakovou E, Kanellias N, Terpos E, Dimopoulos MA, Kastritis E. Theodorakakou F, et al. Among authors: eleutherakis papaiakovou e. Hemasphere. 2023 May 31;7(6):e908. doi: 10.1097/HS9.0000000000000908. eCollection 2023 Jun. Hemasphere. 2023. PMID: 37275739 Free PMC article. No abstract available.
Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes.
Kastritis E, Gavriatopoulou M, Solia E, Theodorakakou F, Spiliopoulou V, Malandrakis P, Ntanasis-Stathopoulos I, Migkou M, Kokkali N, Eleutherakis-Papaiakovou E, Syrigou R, Fotiou D, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: eleutherakis papaiakovou e. Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):844-849. doi: 10.1016/j.clml.2023.07.013. Epub 2023 Aug 1. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37599164
Rituximab-based treatments in Waldenström's macroglobulinemia.
Dimopoulos MA, Kastritis E, Roussou M, Eleutherakis-Papaiakovou E, Migkou M, Gavriatopoulou M, Tassidou A, Terpos E. Dimopoulos MA, et al. Among authors: eleutherakis papaiakovou e. Clin Lymphoma Myeloma. 2009 Mar;9(1):59-61. doi: 10.3816/CLM.2009.n.015. Clin Lymphoma Myeloma. 2009. PMID: 19362975 Review.
82 results